Back to Search
Start Over
The Addition of Rituximab to CVP (Bagley) + Interferon-α as Induction Regimen, Significantly Increases Complete Remission Rates and Progression Free Survival In Intermediate-High Risk Follicular Lymphoma Patients (LNH-pro vs. LNH-pro-05 trial)
- Source :
- Blood; November 2010, Vol. 116 Issue: 21 p2867-2867, 1p
- Publication Year :
- 2010
-
Abstract
- Abstract 2867
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 116
- Issue :
- 21
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs56689394
- Full Text :
- https://doi.org/10.1182/blood.V116.21.2867.2867